Reply to a. Avan et Al
- PMID: 25870094
- DOI: 10.1200/JCO.2015.60.8398
Reply to a. Avan et Al
Erratum in
-
Errata.J Clin Oncol. 2019 Feb 1;37(4):354. doi: 10.1200/JCO.18.02211. J Clin Oncol. 2019. PMID: 30695658 Free PMC article. No abstract available.
Comment on
-
Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer.J Clin Oncol. 2014 Nov 20;32(33):3753-61. doi: 10.1200/JCO.2013.54.5384. Epub 2014 Oct 20. J Clin Oncol. 2014. PMID: 25332247 Clinical Trial.
-
Biomarker Analysis in CLEOPATRA: Searching for a Sensitive Prognostic Factor in Breast Cancer.J Clin Oncol. 2015 May 20;33(15):1711-2. doi: 10.1200/JCO.2014.60.4702. Epub 2015 Apr 13. J Clin Oncol. 2015. PMID: 25870088 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
